Moneycontrol Be a Pro
Get App
Last Updated : Jul 19, 2019 01:31 PM IST | Source:

Hold Torrent Pharmaceuticals; target of Rs 1720: Sharekhan

Sharekhan recommended hold rating on Torrent Pharmaceuticals with a target price of Rs 1720 in its research report dated July 18, 2019.

Broker Research @moneycontrolcom
  • bselive
  • nselive
Todays L/H

Sharekhan's research report on Torrent Pharmaceuticals

USFDA classifies Dahej facility under OAI; Although existing operations are not impacted, future product approvals from this facility could get delayed. We expect Q1FY2020 to be a good quarter due to operational leverage from the acquired domestic business. We expect Torrent Pharma to report sales and adjusted profit CAGR of 17% and 43%, respectively, over FY2019-FY2021E.


We maintain our Hold recommendation on Torrent Pharmaceuticals Limited (Torrent Pharma) with unchanged PT of Rs. 1,720.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

The Great Diwali Discount!
Unlock 75% more savings this festive season. Get Moneycontrol Pro for a year for Rs 289 only.
Coupon code: DIWALI. Offer valid till 10th November, 2019 .
First Published on Jul 19, 2019 01:31 pm
Follow us on
Available On
PCI DSS Compliant